SKHCF (SKHCF) Stock Price & Analysis
SKHCF (SKHCF) rose 21.50% to USD 14.58 as of June 10, 2026 at 01:56 UTC, according to Nexqual real-time market data.
SKHCF last closed at USD 12; the session ranged USD 14.29–14.58 on volume of 5,010 shares. Market capitalization is $7.72B, with a 52-week range of USD 12–19.34 (PNK). Source: Nexqual, June 10, 2026 at 01:56 UTC.
Key Statistics (as of June 10, 2026 at 01:56 UTC)
| Price | USD 14.58 |
|---|---|
| Change | ▲ 21.50% (up) |
| Previous Close | USD 12 |
| Open | USD 14.29 |
| Day Range | USD 14.29 – 14.58 |
| 52-Week Range | USD 12 – 19.34 |
| Volume | 5,010 shares |
| Market Cap | $7.72B |
| Exchange | PNK |
Technical Analysis (SKHCF)
Nexqual's technical model rates SKHCF "SELL" based on 1 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 01:56 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 19.28 (oversold) |
| vs SMA50 | Above (USD 13.33) |
| MACD | -0.5 (negative) |
Analyst Ratings (SKHCF)
Wall Street analysts rate SKHCF "None", per Nexqual as of June 10, 2026 at 01:56 UTC.
| Consensus Rating | None |
|---|
Earnings (SKHCF)
Source: Nexqual, June 10, 2026 at 01:56 UTC.
Financials & Fundamentals (SKHCF)
| Total Revenue | $10.42B |
|---|---|
| Revenue Growth (YoY) | +16.60% |
| Gross Margin | +32.84% |
| Operating Margin | +8.98% |
| Profit Margin | +5.18% |
| ROE | +6.63% |
| Debt / Equity | 68.22 |
| Current Ratio | 1.01 |
| Total Cash | $557.12M |
| Total Debt | $5.95B |
| Free Cash Flow | $597.78M |
Source: Nexqual, June 10, 2026 at 01:56 UTC.
Financial Health Score (SKHCF)
Nexqual rates SKHCF's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 01:56 UTC.
| Growth | Solid — Revenue +7% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 33%, operating 9% |
| Balance Sheet | Solid — $557M cash vs $5.95B debt |
| Cash Flow | Solid — FCF $598M, 6% margin |
| Efficiency | Mixed — ROE 7%, ROA 3.8% |
Ownership (SKHCF)
| Insider Ownership | +7.99% |
|---|---|
| Institutional Ownership | +48.56% |
| Shares Outstanding | 494.24M |
| Float | 458.20M |
Source: Nexqual, June 10, 2026 at 01:56 UTC.
Leadership (SKHCF)
SKHCF is led by James Pacey Newcombe, MD, CEO & Executive Director, per Nexqual as of June 10, 2026 at 01:56 UTC.
| MD, CEO & Executive Director | James Pacey Newcombe |
|---|---|
| Finance Director, CFO & Executive Director | Christopher David Wilks B.Com., F.A.C.I.D., F.A.I.C.D. (age 67) |
| Group Chief Operating Officer | Evangelos Kotsopoulos |
Major Backers & Investors (SKHCF)
Notable institutional backers of SKHCF include Fidelity, John Hancock Investment Trust-Disciplined Value International Fund, TRANSAMERICA FUNDS-Transamerica International Equity, according to Nexqual as of June 10, 2026 at 01:56 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 1.08% |
| John Hancock Investment Trust-Disciplined Value International Fund | 0.92% |
| TRANSAMERICA FUNDS-Transamerica International Equity | 0.35% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.27% |
| BlackRock | 1% |
| Dimensional Fund Advisors | 0.35% |
Source: Nexqual, June 10, 2026 at 01:56 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SKHHY | Sonic Healthcare Ltd. | USD 13.87 | ▲ 2.51% |
| STMEF | STMicroelectronics N.V. | USD 71.01 | ▲ 0.64% |
| CLPXY | China Longyuan Power Group | USD 8.59 | ▲ 1.66% |
| JPXGY | Japan Exchange Group, Inc. | USD 12.87 | ▲ 5.84% |
| PTAIY | PT Astra International | USD 5.17 | ▲ 1.37% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 01:56 UTC. This page is informational and not investment advice.